Dialysis Market (2024-2031)
The Dialysis Market was valued at $20.26 billion in 2023. This market is expected to reach $36.6 billion by 2031, from an estimated $21.92 billion in 2024, at a CAGR of 7.6% during the forecast period 2024-2031. Dialysis Market Size & Forecast Hemodialysis is a treatment for kidney failure patients
- Published
- Mar 2024
- Pages
- 310
- Format
- PDF + Excel
- Report ID
- MRHC - 104441
- Base year
- 2023
- 2023 · BASELINE
- $20.26B
- 2031
- $36.60B
- CAGR 2024–2031
- 7.6%
2023 baseline · 2024–2031 forecast at 7.6% CAGR · hover a bar for the value
Key highlights
Among the Hemodialysis Products, the Consumables Segment is Expected to Account for the Largest Share of the Market in 2024
Among the Peritoneal Dialysis Products, the Dialysate Segment is Expected to Account for the Largest Share of the Market in 2024
Among the Types, the Conventional Segment is Expected to Account for the Largest Share of the Market in 2024
Among the End Users, the Hospitals Segment is Expected to Account for the Largest Share of the Market in 2024
Asia-Pacific: Fastest-growing Regional Market
Report summary
| Particulars | Details |
|---|---|
| Number of Pages | ~310 |
| Format | |
| Forecast Period | 2024-2031 |
| Base Year | 2023 |
| CAGR | 7.6% |
| Estimated Market Size (Value) | $36.6 million by 2031 |
| Segments Covered | Hemodialysis Market Size & Trend Analysis—by Product · Hemodialysis Machines · Centre Hemodialysis/Hemodiafiltration · Home Hemodialysis · Hemodialysis Consumables · Dialyzers by Type · High Flux Dialyzers · Low Flux Dialyzers · Dialyzers by Material · Synthetic Membranes · Regenerated Cellulose Membranes · Blood Lines · Double-needle Therapy · Single-needle Therapy · Single-needle Cross-Over · Hemodiafiltration · Dialysates/HD Concentrates · Alkaline Concentrates · Acidic Concentrates · Dialysis Access Products · Central Venous Catheter (CVC) · Arteriovenous Fistula (AV Fistula) · Arteriovenous Graft (AV Graft) · Hemodialysis Bicarbonate Solutions · Other Hemodialysis Consumables & Accessories · (Note: Other hemodialysis consumables & accessories include filters, disinfectants, syringes, guidewires, needles, heparin caps, applicator cases, etc.) · Hemodialysis Software & Services · Hemodialysis Market Size & Trend Analysis—by Type · Conventional Hemodialysis · Short Daily Hemodialysis · Nocturnal Hemodialysis · Peritoneal Dialysis Market Size & Trend Analysis—by Product · Systems · Catheters · Bags and Tubes · Transfer Sets · Dialysate · Other Peritoneal Dialysis Products · Software & Services · (Note: Other peritoneal dialysis products include clamps, transfer set holders, dialyzer holders, etc.) · Peritoneal Dialysis Market Size & Trend Analysis—by Type · Continuous Ambulatory Peritoneal Dialysis (CAPD) · Ambulatory Peritoneal Dialysis (APD) · Dialysis Water Treatment Systems Market Size & Trend Analysis—by Type · Central Dialysis Water Treatment · Portable Dialysis Water Treatment · Bicarbonate Mixing Systems · Dialysis Market Size & Trend Analysis—by Disease Indication · End Stage Kidney Disease (ESKD) · Acute Kidney Injury (AKI) · Multiple Organ Failure · Other Indications · (Note: Other Indications include septic shock and chronic kidney disease (CKD) (Phase 3 & Phase 4)) · Dialysis Market Size & Trend Analysis—by End User · Hospitals · Homecare Settings · Independent Dialysis Centers |
| Countries Covered | North America (U.S. and Canada), Europe (Germany, France, U.K., Italy, Spain, Switzerland, Netherlands, Belgium, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia-Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa. |
| Key Companies | Becton, Dickinson and Company (BD) (U.S.), Dialife SA (Switzerland), Fresenius Medical Care AG & Co. KGAA (Germany), Asahi Kasei Medical Co., Ltd. (Subsidiary of Asahi Kasei Corporation) (Japan), Wego Healthcare (Shenzhen) Co. Ltd. (China), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Medtronic plc (U.S.), Kawasumi Laboratories, Inc. (Japan), Nipro Corporation (Japan), Quanta Dialysis Technologies, Ltd. (U.S.), and Toray Industries, Inc. (Japan). |
Report overview
Segments covered: product, end user. Regions: North America, Europe, Asia-Pacific, Latin America.
Hemodialysis is a treatment for kidney failure patients in which wastes, salts, and fluid are removed from a patient's blood. In peritoneal dialysis, the abdominal cavity's peritoneum cleans the kidney. Dialysis machines, dialyzers, bloodlines, catheters, and dialysates are required to carry out the dialysis treatment.
Report infographic
Market dynamics
2 factors across 2 forcesTechnological Advancements in Dialysis Machines to Offer Market Growth Opportunities
Dialysis machines with advanced technologies are designed to improve patient care, optimize treatment delivery, and reduce care variations. Enhancements have been attributed to hemodialysis technology's many subsections, such as membrane materials, membrane configurations, pore size distributions, and cut-off & membrane modalities. In 2019, the Innovations in Dialysis—Expediting Advances Symposium (IDEAS) Conference was held to bring together innovators of wearable, portable, and implantable dialysis technologies, including researchers, entrepreneurs, physicians, patients, industry representatives, and government officials committed to improving the outcomes and reducing cost for people with ESKD.
In response to the need for cost-effective dialysis options, in November 2022, the American Kidney Fund, Inc., launched the Patient Access Initiative, a new effort to address ongoing healthcare access issues faced by patients with kidney disease, including rare kidney disease.
In addition, the need for more highly refined methods of creating a more quickly accessible permanent vascular access and the opportunity to develop assistance in cannulation and removal of needles will enhance the reliability of the dialysis procedure. Various companies are focusing on various organic and inorganic strategies to enhance their presence in this market. Some of these are mentioned below:
- In February 2024, Fresenius Medical Care (FME) (U.S.) received U.S. Food and Drug Administration (FDA) 510(k) clearance for its 5008X Hemodialysis System. The company estimates that a 5008X hemodiafiltration system can replace around 160,000 standard hemodialysis machines that are currently operating in the dialysis centers of the country.
- In April 2023, Medtronic plc (U.S.) and DaVita Inc. (U.S.) launched Mozarc Medical (U.S.), a company focusing on kidney healthcare and driving patient-centered technology solutions that will enhance overall patient care and increase access to kidney healthcare globally.
New dialysis modalities, combining medium cut-off membranes and internal filtration to enhance clearance of middle and large molecular compounds, are currently being explored. Tailoring the electrolyte prescription and dialysate composition to the patient's current condition further aims to improve dialysis by 2030.
Studies have shown that survival in end-stage renal disease and overall health are better with home dialysis. There have been advances in in-home dialysis technologies that have simplified hemodialysis, allowing it to be performed in the comfort of a patient’s home. The advanced, smaller dialysis machines and more uncomplicated blood tubing make it easier to manage. The treatment can be done in the patient’s free time by having short daily sessions or a more extended session at night. Other advantages of home hemodialysis are gentle fluid removal and better phosphorous control. Thus, technological advancements in dialysis machines are expected to boost the dialysis market.
Table of contents
15 chapters · 138 sections · 310 pages · click to expandSegmental analysis
| Segment | Largest share (2024) | Fastest growth (2024–2031) |
|---|---|---|
| By Hemodialysis Product | Consumables | — |
| By Peritoneal Dialysis Product | Dialysate | — |
| By Type | Conventional | — |
| By End User | Hospitals | — |
By Hemodialysis Product
- The consumables segment is expected to account for the largest share of the hemodialysis market.
- The largest share of the segment is attributed to the increasing number of patients with chronic kidney disease (CKD), or kidney failure, the rising demand for hemodialysis consumables at home and dialysis centers, and government initiatives such as Medicare (U.S.), which covers up to 80% cost of home hemodialysis.
By Peritoneal Dialysis Product
- The Dialysate Segment is Expected to Account for the Largest Share of the Market in 2024
- The peritoneal dialysis dialysate segment is expected to account for the largest share of the peritoneal dialysis market.
- The need for dialysate solutions at every stage of peritoneal dialysis, high demand for dialysate solutions, and increasing demand for peritoneal dialysis due to its advantages are contributing to the large share of the segment.
By Type
- The conventional segment is expected to account for the largest share of the hemodialysis market.
- Conventional hemodialysis offers the benefits of home therapy with regard to patient power and flexibility.
- Limiting treatment to three times per week helps reduce the patient and caregiver treatment burden.
- Additionally, patients' high preference for conventional hemodialysis is among the major factors leading to the large share of the segment.
By End User
- The hospitals segment is expected to account for the largest share of the dialysis market.
- From 2010 to 2030, due to the increased risk of chronic diseases such as hypertension and diabetes, the prevalence of kidney failure is expected to double.
- With this prevalence, the need for renal replacement therapy is also expected to increase.
- Renal replacement therapy can be achieved through different types of dialysis and kidney transplants.
- The choice of kidney transplants is limited due to its complexity, cost, and donor availability.
- Therefore, dialysis remains the choice to consider as support treatment.
- Therefore, hospitals are highly preferred by patients for their treatment, which is expected to support the large share of the segment.
- The End Stage Kidney Disease (ESKD) Segment is Expected to Account for the Largest Share of the Market in 2024
- The end stage kidney disease segment is expected to account for the largest share of the dialysis market.
- The increasing number of patients with diabetes, heart diseases, and urinary tract blockage leads to high possibilities of ESKD, and the increasing prevalence of ESKD and recurrent kidney infections are some of the major factors driving the growth of this segment.
Geographic analysis
Asia-Pacific
Fastest growthAsia-Pacific is one of the fastest-growing markets for dialysis. Factors such as the increasing number of independent dialysis centers, increasing awareness about dialysis treatment modalities, and favorable government policies are propelling the demand for dialysis products in the region. However, affordability, access to treatment in rural areas, and the lack of skilled professionals are challenging the growth of this market. Asia-Pacific: Fastest-growing Regional Market
Competitive landscape
The report offers a competitive landscape based on an extensive assessment of the product offerings and geographic presence of leading market players and the key growth strategies adopted by them in the last three to four years. The key players profiled in the dialysis market report are Becton, Dickinson and Company (BD) (U.S.), Dialife SA (Switzerland), Fresenius Medical Care AG & Co. KGAA (Germany), Asahi Kasei Medical Co., Ltd. (Subsidiary of Asahi Kasei Corporation) (Japan), Wego Healthcare (Shenzhen) Co. Ltd. (China), Baxter International, Inc. (U.S.), B. Braun Melsungen AG (Germany), Medtronic plc (U.S.), Kawasumi Laboratories, Inc. (Japan), Nipro Corporation (Japan), Quanta Dialysis Technologies, Ltd. (U.S.), and Toray Industries, Inc. (Japan).
- Becton
- Dickinson and Company (BD) (U.S.)
- Dialife SA · Switzerland
- Fresenius Medical Care AG & Co. KGAA · Germany
- Wego Healthcare (Shenzhen) Co. Ltd. · China
- Baxter International, Inc. (U.S.)
- B. Braun Melsungen AG · Germany
- Medtronic plc (U.S.)
- Kawasumi Laboratories, Inc. · Japan
- Nipro Corporation · Japan
- Quanta Dialysis Technologies, Ltd. (U.S.)
- Toray Industries, Inc. · Japan
Frequently asked questions
The dialysis market refers to the global industry surrounding products, services, and technologies used for dialysis treatments, which are essential for individuals with kidney failure or chronic kidney disease (CKD). Dialysis treatments, including hemodialysis and peritoneal dialysis, remove waste, salts.
Cite this report
Meticulous Research. (2024). Dialysis Market - Global Opportunity Analysis and Industry Forecast (2024-2031) (Report No. MRHC - 104441). Meticulous Market Research Pvt. Ltd. https://www.meticulousresearch.com/product/dialysis-market-5137